Search

There are many studies showing beneficial psychophysical effects of exercise in dialyzed patients. Moreover, it has been suggested that exercise positively correlates with better metabolism, better blood pressure control and with total hemoglobin. In our dialysis unit eight dialyzed patients (average age = 66.7 years), for eight weeks participated in physical training with bike (Reck Moto Med Letto) during dialysis treatment. Controls of glucose metabolism, blood pressure and dialysis efficiency index (Kt/V and URR) at rest and during exercise was performed. All patients responded well to exercise and expressed better muscular performance during and after exercise time. Our study showed in all patients improvement of Kt/V and URR index after physical exercise period, compared to exercise free time (p < 0.005). We suggest that exercise during dialysis treatment is safe and consents either better psychophysical performance or better dialytic efficiency.

Nephrotic syndrome has been described in association with solid tumours, such as carcinoma of the lung or colon, whilst the relationship between urinary tract cancers and proteinuria is reported less frequently. We describe a case of a 75-year-old man with nephrotic syndrome and relapsing transitional cell carcinoma affecting the bladder. Renal biopsy showed membranous nephropathy. The patient underwent four transurethral tumour resections and each time we observed improved proteinuria by 3-4 weeks after surgery. On the contrary, steroid treatment was clearly unrelated to this improvement. We conclude that, at least in this case, surgical treatment of the tumour led to improved proteinuria whilst steroid treatment was not beneficial.

Background: Even though many organs may be involved and clinical manifestations are extremely variable, a sudden worsening of renal function after vascular surgery or invasive angiographic manoeuvres is a clue for the diagnosis of renal cholesterol crystal embolization. In rare cases the disease may also occur spontaneously during anticoagulant or thrombolytic therapy. Renal atheroembolism is becoming increasingly recognized as an important cause of renal failure particularly in elderly men, and is often associated with a bad outcome. To date there is no specific and proven useful treatment apart from a few anecdotal reports on the benefits of corticosteroids., Patients and Methods: We report a group of seven patients with cholesterol atheroembolic disease presenting acute renal failure; in six patients the disease appeared after coronary arteriography and PTCA performed in the last four months, and in one patient in an apparently spontaneous form. All the patients presented cutaneous lesions, livedo reticularis, purpuric rush, necrosis of the toes; laboratory data showed an increase of acute phase proteins and eosinophilia. Results. Treatment with prednisolone was begun at a dose of 40 mg/day i.v. for four days; the dose was reduced to prednisone 0.4-0.5 mg/kg/day for 1 week, than gradually reduced further and stopped within a month. Following therapy renal function rapidly improved; clinical symptoms of malaise and abdominal discomfort subsided, with amelioration of skin lesions and cyanosis of toes., Conclusions: Despite the small number of patients studied, our experience suggests that corticosteroid treatment is an effective therapeutic option in cholesterol renal atheroembolic disease, especially in the more severe cases of acute renal failure.